Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Vinegar amount in the process affected the components of vinegar-baked Radix Bupleuri and its hepatoprotective effect

BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201616:346

https://doi.org/10.1186/s12906-016-1333-4

Received: 8 May 2016

Accepted: 31 August 2016

Published: 6 September 2016

Abstract

Background

Bupleuri Radix (in Chinese Chaihu), the dried roots of Bupleurum Chinense DC, is a traditional Chinese medicine widely used to treat fever, hepatitis, jaundice, nephritis, dizziness. When baked with vinegar, its effect is more focused on liver related disease. This paper was undertaken to determine the best vinegar amount in the processing and explore its key efficacy components.

Methods

Hepatoprotective effects of Radix Bupleuri after processing with different amount of vinegar (1:5, 2:5, 3:5) were investigated on liver hurt rats, and the change of constituents were analyzed by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS).

Results

With the increasing amount of vinegar, the hepatoprotective effects of vinegar-baked Radix Bupleuri (VBRB) and the content of saikosaponin bincreased.

Conclusion

These results suggested that vinegar amount in the process affected the pharmacological effect of VBRB significantly and saikosaponin b2 may be the key efficacy component of it.

Keywords

Vinegar amount Vinegar-baked Radix Bupleuri Hepatoprotective effect Saikosaponin

Background

Radix Bupleuri (Chaihu), the radix of Bupleurum Chinense DC is a well-known traditional Chinese medicine (TCM) usually used for curing influenza, fever, malaria, hepatitis, jaundice, nephritis, dizziness, bitter taste in mouth, lung diseases, cancer, and menstrual disorders in Asian countries [17]. Radix Bupleuri always used in liver -related disease in clinic, and modern pharmacology research also proved that radix Bupleuri had hepatoprotective effects. Xie DH et al. adopted dimethylnitrosamine –induced chronic liver fibrosis in rats, and compared protective liver action of north Chaihu and spring Chaihu on blood biochemical indexes, the content of hepatic tissue collagen protein and liver cell apoptosis. Spring Chaihu and north Chaihu have protective effect on anti- liver fibrosis in rats, north Chaihu is better than spring Chaihu on protective liver action [8]. Guinea MC showed that both the saponin fraction and the isolated compound of Bupleuri showed substantial hepatoprotective effects against d-galactosamine [9]. Yen MH et al. demonstrated that the hepatoprotective effects of water extract, both polysaccharide- and saponin-enriched fractions of B. kaoi in rats [10]. Mohamed L. et al. concluded that the high concentrations of triterpene saponins and polyphenolics significantly contribute to the observed hepatoprotective effects of Bupleurum spp. through reviewing the literature [11].

Prior to its usage in clinics, Radix Bupleuri is usually subjected to traditional Chinese processing techniques (PaoZhi). When Radix Bupleuri is baked with vinegar, it’s effect even more focus on liver [1214]. Some people compared the pharmacological effects and found that after the vinegar baked process, acesodyne and bile secretion enhancing effect of Radix Bupleuri increased significantly [15, 16]. Li ZY et al. compared the chemical compositions by 1H NMR spectroscopy coupled with multivariate analysis and biological effects against CCl4 induced liver injury between raw and two processed Radix Bupleuri by different types of vinegars and found that VBRB had a more strong hepatoprotective effect, meanwhile the content of saikosaponin a and d decreased and saikosaponin b2 increased, and VBRB with a higher saikosaponin b2 seems had a better effect [17]. Saikosaponin b2 is a metabolite of saikosaponin d, and above results indicated that its content may be related with vinegar amount in the processing.

Ancient literature records three different amount used in the vinegar process, that is vinegar: Radix Bupleuri (1:5, 2:5, 3:5). In Pharmacopeia of China, 1:5 ratio is used, but no evidence showed which amount is the best and which component responds for the pharmacological change. Therefore, in this study, the hepatoprotective effects of VBRB with different amount of vinegar in the angry model induced by tail clamping methods was compared, and meanwhile the components of VBRB was analyzed. These data gave some clues for the processing quality control and active integrants of VBRB.

Methods

Plant material and processing technology with different amount of vinegar

The decoction pieces of Radix Bupleuri were purchased from Kangmei Medical Company (Guangzhou, China) and the batch number was 14061371. The purchased samples were identified by Ruizhi Zhao (the corresponding author) and voucher specimens were deposited in Materia Medica Preparation Lab of Second Affiliated Hospital, Guangzhou University of Chinese Medicine. The decoction pieces of Radix Bupleuri were soaked with vinegar (the ratio were 5:1, 5:2, 5:3, respectively) for 6 h until the vinegar was completely absorbed, then baked in electric oven at 100 °C for 2.5 h and stirred every 30 min during the time. The VBRB were taken out and cooled to room temperature for next use.

Chemicals and reagents

Rice vinegar was purchased from Beijing Er Shang Longhe Food Co. Ltd (Beijing, China). Saikosaponin a, b2, c, d (all purity ≥98.0 %) was purchased from Shanghai Winherb Medical S&T Development Co. Ltd (Shanghai, China). The HPLC-grade reagents acetonitrile, and formic acid were obtained from Fisher Scientific ((Fairlawn, NJ, USA). All other chemicals were of analytical grade. Aspertate aminotransferase (AST), Alanine aminotransferase (ALT), Total bilirubin (TBIL), direct bilirubin (DBIL) and total bile acid (TBA) assay kits were purchased from Rocher Diagnostics Ltd (Germany).

Animals and their care

SD rats, male, 280–320 g, were provided by Guangdong Medical Laboratory Animal Center, and their certificate number was 0116066. They were acclimatized in an air conditioned room at 22 ± 2 °C for 3 days with a 12 h light and 12 h darkness cycle. All animals were free to standard laboratory chow and tap water before experiment. The studies were approved by the Animal Ethics Committee of Guangdong Province Hospital of Traditional Chinese Medicine.

Extract of VBRB for animal experiment

One-hundred grams of VBRB (1:5, 2:5, 3:5) were soaked in 10 times of water for 0.5 h, then boiled for 1 h and filtered. The residues were extracted for other two times with 8 times of water for 40 min and filtered. The filtrate was combined and condensed to 100 mL (water extract) at 60 °C under reduced pressure, and finally freeze-dried.

Induction of liver hurt model and drug treatment

The rats were randomly divided into five groups with 10 rats each, including a normal control group, model group, VBRB processed with different amount of vinegar (1:5, 2:5, 3:5) group. Except for rats in normal control group, the tails of all other rats were clamped about 30 min by folder 4 times per day for 7 days to induce liver hurt model. Then all rats were fasted except for water for 12 h, 600 mg/kg of VBRB (1:5, 2:5, 3:5) were given to the rats in the treating group respectively. Normal control group and model group received the same amount of distilled water.

Biochemical assays

At the end of this experiment, rats were injected 10 % chloral hydrate intraperitoneally at a concentration of 0.30 mL/100 g, and blood samples were collected from the retinal vein plexus. Blood was allowed to clot and centrifuged at 3500 rpm for 10 min, then the serum were collected for determine the content of AST, ALT, ALP, TBIL, DBIL and TBA by kits according to the manufacturers’ protocol.

Preparation of standard solutions and VBRB samples for UPLC-MS/MS analysis

Saikosaponin a, b2, c, d were accurately weighed and dissolved in 70 % methanol to get standards stock solutions (0.32 mg/mL, 0.20 mg/mL, 0.18 mg/mL, 0.22 mg/mL respectively), then they were kept at 4 °C until use.

The water extract of Radix Bupleuri and VBRB with the herb concentration of 1 g/mL was obtained by using the method described in samples for animal experiment. Then the extraction was added appropriate amount of 95 % ethanol to adjust the ethanol concentration to 80 %; and the mixture was kept overnight and then centrifuged at 3500 rpm for 30 min. The residue was freeze-dried (BC1), and the supernatant was condensed by removing ethanol and further extracted by n-butanol. The n-butanol layer (BC2) and water layer (BC3) were separated and condensed, and the residues were freeze-dried, and weighted. For saikosaponins determination, dried powder of water extract were dissolved and diluted in 70 % methanol at a concentration of 0.1 mg · mL−1 (calculated on the amount of raw materials), then centrifuged at 3500 rpm for 10 min. The supernatant were filtered through a 0.22 μm membrane filter before injecting into UPLC-MS/MS.

UPLC-MS/MS system

Chromatographic separation was performed on a Waters Acquity ultra performance liquid chromatography (UPLC) consisted of a binary pump and a sample manager. The MS analysis was performed using Waters Xevo TQ-S Mass Spectrometer coupled with ESI source. The analytes were separated on a Thermo Hypersil GOLD C18 column (1.9 μm, 2.1 mm × 100 mm, Thermo scientific). The column temperature was 25 °C. The mobile phase consisted of the solvent A (acetonitrile) and B (0.1 % formic acid). The gradient elutionstarted at 30 % A, ramped linearly to 50 % A in 15 min, then directly increased to 100 % A for 0.5 min and returned to the initial percentage. The flow rate was 400 μL/min and the injection volume was 5 μL. The ESI-MS was operated on negative mode at a spray voltage of 3.0 kV. Nitrogen was used as the vacuum gas, desolvation gas (1000 L/h) and cone gas (150 L/h). Argon was used as collision gas (0.15 mL/min). The temperature of the source and desolvation were set at 150 and 500 °C. Multiple reaction monitoring (MRM) was employed for quantification. The parent-to-product ion pair, cone voltage and collision energy for saikosaponin a, b2, c, d were described in Table 1.
Table 1

Mass spectrum properties of four compounds

Compound Name

Parent Ion

Product Ion

Cone Voltage (V)

Collision Voltage (V)

Saikosaponin a

779.6

617.5

100

34

Saikosaponin b2

779.6

617.5

100

30

Saikosaponin c

925.7

101.1

100

50

Saikosaponin d

779.7

617.5

100

36

Validation of the quantitative analysis

The linearity calibration curves of saikosaponin a, b2, c, d were constructed by eight different concentrations and each concentration was analyzed in triplicate, then the calibration curves were established by the plotting peak areas versus the concentrations of standard solutions. The intra-day precision was performed by analysis of six replicates within 1 day, and the inter-day precision was determined by repeated analysis of the sample in consecutive 3 days. Recovery was determined using the spiked samples. Known amount of standard solution was added into accurately weighed Radix Bupleuri samples. The mixtures were extracted and analyzed using the method described in sample preparation for evaluating the accuracy. The average recoveries were determined by the following equation: Recovery (%) = (Observed amount-Original amount)/Spiked amount × 100 %. For repeatability test, six independent sample solutions were prepared and analyzed. Variations were expressed by relative standard deviation (RSD) in above three tests.

Statistical analysis

Data analysis was performed using SPSS 17.0, all datas were expressed as mean ± SD. One way ANOVA tests were applied when homogeneity of variance assumptions are satisfied, otherwise the equivalent non-parametric test were used. P < 0.05 was considered significant.

Results

Effect of VBRB on ALT and AST level

Effects of VBRB processed by different amount of vinegar on the content of ALT and AST were shown in Fig. 1. The contents of ALT and AST in model rats were significantly higher than those in normal control group (P < 0.05, P < 0.01). After treated with VBRB (1:5), VBRB (2:5), VBRB (3:5), the ALT and AST level were decreased with the increased amount of vinegar, but not significant except for the AST level in group VBRB (3:5) rats (P < 0.05).
Fig. 1

Effect of vinegar-baked Radix Bupleuri on ALT (a) and AST (b) level (* P < 0.05, **P < 0.01 compared with normal group; #P < 0.05 compared with model group)

Effect of VBRB on TBIL, DBIL and TBA level

Effects of VBRB processed with different amount of vinegar on contents of TBIL, DBIL and TBA were shown in Fig. 2. TBIL and DBIL level in all group didn’t change remarkably, but contents of TBA increased significantly in model rats compared to normal control group (P < 0.05). After treatment, the TBA level were decreased in sequence from VBRB (1:5), VBRB (2:5) to VBRB (3:5), and only the difference in group VBRB (3:5) were significant (P < 0.05).
Fig. 2

Effect of vinegar-baked Radix Bupleuri on TBIL (a), DBIL (b) and TBA (c) level (* P < 0.05 compared with normal group; #P < 0.05 compared with model group)

Comparison of the extracting rates of VBRB processed with different amount of vinegar effect

The extraction rates of different extraction parts of Radix Bupleuri and VBRB (calculated by raw material) were listed on the Table 2. The results showed that the extracting rates of total extract increased as the proportion of vinegar increased, so as the part of BC1, BC2 and BC3.
Table 2

The extracting rates of every part of Radix Bupleuri and it’s different proportion of vinegar processing product

Samples

BC1 (%)

BC2 (%)

BC3 (%)

Total (%)

Radix Bupleuri

5.108

5.240

4.339

14.687

VBRB (1:5)

5.253

5.348

4.875

14.593

VBRB (2:5)

5.385

5.877

4.996

16.259

VBRB (3:5)

6.763

6.214

6.547

18.921

Method validation of the quantitative analysis

The calibration curves were prepared by assaying standard solutions as described above. The regression equations were constructed by the peak area (y) vs. concentration (x, ng/mL) and the result showed the linear relationship was good (r2 ≥ 0.9990). The limit of quantitation (LOQ) of saikosaponin a, b2, c, d were in the range of 4.03–14.55 ng/mL (Table 3). The intra- and inter-day precisions calculated as RSD were 1.42–3.89 % and 1.80–3.58 %, respectively. The overall repeatability variations were 2.84–4.08 % and the recoveries of analytes were higher than 98 %. These results indicated that this UPLC-MS/MS method is precise, accuracy and sensitive enough for simultaneously quantitative evaluation of the four saikosaponins in VBRB. Representative TIC chromatograms of samples are shown in Fig. 3.
Table 3

Calibration curves, linear range and LOQ of four saikosaponins

Analytes

Calibration curve

r2(n = 3)

Linear range (ng/mL)

LOQ (ng/mL)

Saikosaponin a

y = 24.935x − 141.99

0.9995

25.60–3200

6.40

Saikosaponin b2

y = 117.23x + 1077.3

0.9996

16.15–2020

4.03

Saikosaponin c

y = 135.96x + 200.53

0.9999

14.55–1820

7.28

Saikosaponin d

y = 103.19x − 274.17

0.9999

17.28–2160

4.32

Fig. 3

UPLC-MS/MS chromatographs of water extract of VBRB (3:5) (a), water extract of Radix Bupleuri (b) and blank solution (c) (1. saikosaponin c; 2. Saikosaponin a; 3. saikosaponins b2; 4. saikosaponin d)

Quantitative determination of saikosaponins in Radix Bupleuri and VBRB

The established UPLC-MS/MS method has been successfully applied to determination of four saikosaponins in Radix Bupleuri which processed by different amount of vinegar. The retention time of saikosaponin a, b2, c, d under the optimized UPLC-MS assay were 6.47, 10.84, 11.22 and 15.35 min, respectively. The contents of four saikosaponins are summarized in Table 4.
Table 4

Contents of four saikosaponins assayed in samples of Radix Bupleuri extracted with water

Samples

Content (mg/g)

Saikosaponin a

Saikosaponin b2

Saikosaponin c

Saikosaponin d

Radix Bupleuri

11.04

4.84

3.52

0.93

VBRB (1:5)

6.44

6.95

1.56

0.16

VBRB (2:5)

4.99

7.32

2.00

0.18

VBRB (3:5)

4.75

9.33

1.98

0.13

Discussion

Traditional Chinese processing techniques (PaoZhi) is one of the commonly used methods for changing drug property, reducing toxicity and improving effects of TCM. It was reported that VBRB had a stronger effect than Radix Bupleuri on bile secreting and hepatoprotective effects [11], and previous study also showed the pharmacological change may be related with the change of components in VBRB [17, 18]. However, the pharmacological study and the component study usually did separately, and temperature, pressure and soaking time were also affecting factors during vinegar processing technology. Therefore, the results couldn’t fully explain the link between components and pharmacology. This paper exclusively explored the influence of vinegar amount on hepatoprotective effect of VBRB and its corresponding change of components after controlling for other factors for the first time.

1:5, 2:5 and 3:5 were the ratios of vinegar to Radix Bupleuri which usually used in the literature. In our previous technology experiments, Vinegar could not be absorbed sufficiently by Radix Bupleuri when the ratio up to 4:5 and the content of saikosaponin b2 changed a little over the ratio of 3:5. Therefore we chose these three ratios for this study.

VBRB usually used in clinic curing liver related disease such as hypochondriac pain, hepatic adipose infiltration, hepatitis etc., which indicated its effect may mainly in liver protection. Alcohol, high lipids diet and abnormal emotion are the main cause of uninfected liver injury, and abnormal emotion especially anger induced model had the benefit of stable and at a shorter time to establish [19, 20]. Therefore we chose this model by angering rats through clamping tails. ALT and AST, are the indexes of evaluating the severity of liver damage. When liver cells are necrotic, the index of ALT and AST increased, and the extent of increased level are accordance with the severity of liver damage. TBIL, DBIL and TBA are the indexes reflecting the secretion, excretion of the bile and the ability to detoxify of liver. Among them, TBA reflects a more sensitive liver function and its level positively correlated with the degree of liver damage. Compared the index of liver function before and after model establishment, the level of ALT, AST and TBA changed obviously which was proved that rats angered by painful stimulus, and anger lead to liver dysfunction. VBRB could improve the liver injury by decreasing the index levels of liver especially the AST and TBA levels on model induced by anger. Among them, the most effective group was group VBRB (3:5).

The efficacy of medicine is closely related to their material basis, so we analyzed the change of constituents of VBRB after processed by different amount of vinegar. The extracting rates of total extract increased with the increasing amount of vinegar in the processing, and the trend was the same in extraction parts of BC1, BC2 and BC3. The result showed that the best amount of vinegar in the processing was 3:5, and this is accordance with that of the results of pharmacology experiment. BC1, mainly containing polysaccharides, had the effect of regulate and enhance immunity [21]. BC3 was mainly composed of low molecular weight water soluble components [22], no reports were found on its pharmacological effects and needed further study. BC2 was mainly composed of saponins which were also the main and bioactive components of VBRB [2224], so we investigated the saponins to seeking the main active compounds of VBRB in follow-up experiment. The results showed that the native saponins (saikosaponin a, c, d) decreased, and the secondary saponin (saikosaponin b2) increased gradually with the increasing proportion of vinegar. Modern research considered that native saponins (saikosaponin a, c, d) were the main effective compounds of Radix Bupleuri, so these saponins usually used as the index components of Radix Bupleuri [2527]. However, similar with our results, other study also showed that secondary saponins (saikosaponin b1, b2) were increased, while the saikosaponin a, saikosaponin c, and saikosaponin d were decreased after the vinegar-baking process [28, 29], and a higher saikosaponin b content also follow a better hepatoprotective effect [17], in spite of that the model they used is CCl4 induced liver injury. It was also reported that the saikosaponin b2 had strong pharmacological effects which could be an efficient inhibitor of early hepatitis C virus entry, including neutralization of virus particles, preventing viral attachment, and inhibiting viral entry/fusion [30]. In this paper, high content of saikosaponin b2 in water extract illustrated that only using the native saponins as the index component of Radix Bupleuri were not complete and realistic. With the increasing amount of vinegar, the secondary saponins even should be more important index compounds. Combined with pharmacological study, we speculated that saikosaponin b2 may be the main active components of VBRB.

Conclusions

In the present study, we compared the hepatoprotctive effects of Radix Bupleuri after processing with different amount of vinegar (1:5; 2:5, 3:5) on anger induced liver damage rats. The group treated with VBRB (3:5) showed the best activity. Meanwhile, we investigated the changes of the components and found that the native saponins (saikosaponin a, c, d) decreased, and the secondary saponin (saikosaponin b2) increased significantly with the increasing proportion of vinegar. So we concluded that the best proportion of vinegar to Radix Bupleuri in vinegar-processing technology was 3:5 and saikosaponin b2 may be one of the key efficacy components of VBRB.

Abbreviations

ALT: 

alanine aminotransferase

AST: 

aspertate aminotransferase

DBIL: 

direct bilirubin

LOQ: 

limit of quantitation

MRM: 

multiple reaction monitoring

RSD: 

relative standard deviation

TBA: 

total bile acid

TBIL: 

total bilirubin

TCM: 

traditional Chinese medicine

UPLC-MS/MS: 

ultra-performance liquid chromatography tandem mass spectrometry

VBRB: 

vinegar-baked Radix Bupleuri

Declarations

Acknowledgements

This research was financially supported by the fund of National Science Foundation of China (Grant No. 30672668, 81073063, 81573612), the Guangdong Natural Science Fund (2015A030313357) and Financial Grant from the China Postdoctoral Science Foundation (2016M592477).

Availability of data and materials

All data and materials are contained and described within the paper.

Authors’ contributions

Dr. ZRZ conceived, designed the research and revised the manuscript; XFJ participated in its design; WYJ and ZY performed experiments; ZY drafted the manuscript. All authors have read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The studies were approved by the Animal Ethics Committee of Guangdong Province Hospital of Traditional Chinese Medicine.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Second Affiliated Hospital, Guangzhou University of Chinese Medicine
(2)
Yipinhong Pharmaceutical Co. Ltd
(3)
The postdoctoral research station, Guangzhou University of Chinese Medicine

References

  1. Cheng PW, Chiang LC, Yen MH, Lin CC. Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. Food Chem Toxicol. 2007;45(1):24–31.View ArticlePubMedGoogle Scholar
  2. Cheng XQ, Song LJ, Li H, Di HY, Zhang YY, Chen DF. Beneficial effect of the polysaccharides from Bupleurum smithii var. parvifolium on “two-hit” acute lung injury in rats. Inflammation. 2012;35(5):1715–22.View ArticlePubMedGoogle Scholar
  3. Lin LF, Shi L, Liu RN, Xu L. The influence of mouse liver after taking the water extract of Bupleurum chinense continuously. Pharmacol Clin Chin Mater Med. 2012;28(2):124–6.Google Scholar
  4. Seo MK, Cho HY, Lee CH, Koo KA, Park YK, Lee JG, Lee BJ, Park SW, Kim YH. Antioxidant and proliferative activities of Bupleuri Radix extract against serum deprivation in SH-SY5Y cells. Psychiatry Investig. 2013;10(1):81–8.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Hu SC, Lee IT, Yen MH, Lee CW, Yen FL. Anti-melanoma activity of Bupleurum chinense, Bupleurum kaoi and nanoparticle formulation of their major bioactive compound saikosaponin-d. J Ethnopharmacol. 2016;17(179):432–42.View ArticleGoogle Scholar
  6. Casiglia S, Bruno M, Senatore F, Senatore F. Chemical composition of the essential oil of Bupleurum fontanesii (Apiaceae) growing wild in Sicily and its activity on microorganisms affecting historical art crafts. Nat Prod Commun. 2016;11(1):105–8.PubMedGoogle Scholar
  7. Kim H, Kim SH, Yun KW. Antioxidant activity and total phenolic contents of three Bupleurum taxa. Nat Prod Commun. 2014;9(4):523–4.PubMedGoogle Scholar
  8. Xie DH, Yuan DP, Cai BC, Zhang LS, Jia RD. Comparative study on protective effect of dimethylnitrosamine (DMN)-induced liver fibrosis in rats of north Chaihu and spring Chaihu. Chin Hosp Pharm J. 2008;28(23):2006–9.Google Scholar
  9. Guinea MC, Parellada J, Lacaille-Dubois MA, Wagner H. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Planta Med. 1994;60(2):163–7.View ArticlePubMedGoogle Scholar
  10. Yen MH, Weng TC, Liu SY, Chai CY, Lin CC. The hepatoprotective effect of Bupleurum kaoi, an endemic plant to Taiwan, against dimethylnitrosamine-induced hepatic fibrosis in rats. Biol Pharm Bull. 2005;28(3):442–8.View ArticlePubMedGoogle Scholar
  11. Ashour ML, Wink M. Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action. J Pharm Pharmacol. 2011;63(3):305–21.View ArticlePubMedGoogle Scholar
  12. Zhao RZ, Chen YJ, Cai JX. Liver targeting effect of vinegar-baked Radix Bupleuri on oxymatrine in mice, Bioinformatics and Biomedicine Workshops (BIBMW), 2011 IEEE Int Conf. 2011. p. 740–5.Google Scholar
  13. Zhao RZ, Liu SJ, Mao SR, Wang YJ. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. J Ethnopharmacol. 2009;126(3):415–20.View ArticlePubMedGoogle Scholar
  14. Zhao RZ, Yuan D, Liu SJ, Chen YJ, Liu LJ, Zhao Y. Liver targeting effect of vinegar-baked Radix Bupleuri on rhein in rats. J Ethnopharmacol. 2010;132(2):421–8.View ArticlePubMedGoogle Scholar
  15. Wu J. Effect of process on components and pharmacological of Radix Bupleurum. Hubei J Tradit Chin Med. 2008;30(9):60–1.Google Scholar
  16. Nie SQ, Yang Q, Li LF, Huang LQ. Pharmacokinetics comparisons of Bupleurum root and red peony root, vinegar-baked Bulpeurum root and white peony root between compatibility and single application. Chin J Expe Tradit Med Form. 2002;8(3):11–4.Google Scholar
  17. Li ZY, Sun HM, Xing J, Qin XM, Du GH. Chemical and biological comparison of raw and vinegar-baked Radix Bupleuri. J Ethnopharmacol. 2015;165:20–8.View ArticlePubMedGoogle Scholar
  18. Xing J, Sun HM, Li ZY, Qin XM. Comparison of volatile components between raw and vinegar baked Radix Bupleuri by GC-MS based metabolic fingerprinting approach. Evid Based Complement Alternat Med. 2015;2015:653791.PubMedPubMed CentralGoogle Scholar
  19. Ahmad AA, Simone ST. Neuroanatomical and neurochemical bases of theory of mind. Neuropsychologia. 2011;49(11):2971–84.View ArticleGoogle Scholar
  20. Pajer KA. Cardiovascular disease risk factors in adolescents: do negative emotions and hypothalamic-pituitary-adrenal axis function play a role? Curr Opin Pediatr. 2007;19(5):559–64.View ArticlePubMedGoogle Scholar
  21. Cheng XQ, Li H, Yue XL, Xie JY, Zhang YY, Di HY, Chen DF. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. J Ethnopharmacol. 2010;130(2):363–8.View ArticlePubMedGoogle Scholar
  22. Yu TY, Chen XZ, Wang YJ, Zhao RZ, Mao SR. Modulatory effects of extracts of vinegar-baked Radix Bupleuri and saikosaponins on the activity of cytochrome P450 enzymes in vitro. Xenobiotica. 2014;44(10):861–7.View ArticlePubMedGoogle Scholar
  23. Chen SM, Sato N, Yoshida M, Satoh N, Ueda S. Effects of Bupleurum scorzoneraefolium, Bupleurum falcatum, and saponins on nephrotoxic serum nephritis in mice. J Ethnopharmacol. 2008;116(3):397–402.View ArticlePubMedGoogle Scholar
  24. Chen XZ, Yu TY, Chen ZX, Zhao RZ, Mao SR. Effect of saikosaponins and extracts of vinegar-baked Bupleuri Radix on the activity of beta-glucuronidase. Xenobiotica. 2014;44(9):785–91.View ArticlePubMedGoogle Scholar
  25. Lu XL, He SX, Ren MD, Wang YL, Zhang YX, Liu EQ. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2. Mol Med Rep. 2011;5(3):637–44.PubMedGoogle Scholar
  26. Wang XT, Wang QG, Burczynski FJ, Kong WS, Gong YW. Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation. Phytomedicine. 2013;20(14):1330–5.View ArticlePubMedGoogle Scholar
  27. Wu SJ, Tam KW, Tsai YH, Chang CC, Chao JCJ. Curcumin and Saikosaponin A inhibit chemical-induced liver inflammation and fibrosis in rats. Am J Chin Med. 2010;38(1):99–111.View ArticlePubMedGoogle Scholar
  28. Jiang H, Li J, Shi RB, Yin WP. Influence of processing on four saikosaponins in Radix Bupleuri. Chin Pharm J. 2009;44(21):1618–21.Google Scholar
  29. Xu L, Tian JX, Song R, Liu GQ, Tian Y, Zhang ZJ. LC-MS/MS determination and comparison of saikosaponin a, b2, c, d in crude and processed radix bupleuri by vinegar. J China Pharm Univ. 2012;43(4):334–40.Google Scholar
  30. Lin LT, Chung CY, Hsu WC, Chang SP, Hung TC, Shields J, Russell RS, Lin CC, Li CF, Yen MH, Tyrrell DLJ, Lin CC, Richardson CD. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J Hepatol. 2014;62(3):541–8.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement